Not applicableUnknownNCT02088710What this trial is testingExpectations and Side Effects of Endocrine Therapy in Women With Breast CancerWho this might be right forFemale Breast Cancer Philipps University Marburg 138
Post-approval studies (Phase 4)UnknownNCT01613170What this trial is testingPremarin Versus Toviaz for Treatment of Overactive BladderWho this might be right forOveractive Bladder The Cleveland Clinic 90
Large-scale testing (Phase 3)Study completedNCT01626222What this trial is testing4EVER - Efficacy, Safety, Health Economics, Translational Research of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer Novartis Pharmaceuticals 301
Testing effectiveness (Phase 2)Study completedNCT00160342What this trial is testingComparison of Estrogen and Methyltestosterone Combination Treatments for Postmenopausal Hot FlushesWho this might be right forHot Flushes, Menopause, Postmenopause Solvay Pharmaceuticals 1,251
Testing effectiveness (Phase 2)Study completedNCT01575522What this trial is testingTivantinib in Treating Patients With Recurrent or Metastatic Breast CancerWho this might be right forEstrogen Receptor NegativeHER2/Neu NegativeProgesterone Receptor Negative+3 more National Cancer Institute (NCI) 22
Testing effectiveness (Phase 2)Looking for participantsNCT06450873What this trial is testingTurkey Tail Mushroom for Treating Post-Menopausal Women With HER2-Negative ER-Positive Breast Cancer Undergoing SurgeryWho this might be right forEstrogen Receptor-Positive Breast CarcinomaHER2-Negative Breast Carcinoma Mayo Clinic 40
Early research (Phase 1)Study completedNCT00745173What this trial is testingStudy Evaluating Premarin and Bazedoxifene Potential InteractionWho this might be right forPostmenopause Wyeth is now a wholly owned subsidiary of Pfizer 30
Early research (Phase 1)Ended earlyNCT03816839What this trial is testingEvaluation of Orally Administered Amcenestrant (SAR439859) in Japanese Postmenopausal Patients With Advanced Breast Cancer (AMEERA-2)Who this might be right forBreast Cancer Sanofi 10
Testing effectiveness (Phase 2)Ended earlyNCT01230970What this trial is testingExploratory Study to Assess the Short Term Intratumoural and Peripheral Effects of BN83495 in Postmenopausal Women With Newly Diagnosed Breast CancerWho this might be right forBreast Cancer Ipsen 2
Testing effectiveness (Phase 2)Looking for participantsNCT07427394What this trial is testingStudy to Evaluate the Safety and Tolerability of Camizestrant in Combination With Atirmociclib in Women With Advanced Breast CancerWho this might be right forAdvanced Breast Cancer AstraZeneca 24
Early research (Phase 1)Looking for participantsNCT07604272What this trial is testingReversing InGuinal Hernia Trial: The Evaluation of Sex Hormones to Reverse Inguinal Hernias in MalesWho this might be right forInguinal Hernia UnilateralInguinal Hernia BilateralInguinal Hernia Without Obstruction or Gangrene+1 more Northwestern University 30
Early research (Phase 1)Study completedNCT03916744What this trial is testingGiredestrant (GDC-9545) in Postmenopausal Women With Stage I-III Operable, Estrogen Receptor-Positive Breast CancerWho this might be right forBreast Cancer Genentech, Inc. 75
Early research (Phase 1)Study completedNCT01436513What this trial is testingCompare The Amount Of Premarin Components That Is Absorbed Into The Blood Of Japanese Healthy Postmenopausal Women Following Oral Administration Of Two Different Tablets Of Premarin Under Fast and Fed Conditions.Who this might be right forPrimary Ovarian InsufficiencyVaginitisMetrorrhagia+1 more Pfizer 72
Not applicableStudy completedNCT03726931What this trial is testingFES (16α-[18F]-Fluoro-17β-estradiol)-PET: Towards a New Standard to Stage Locally Advanced and Recurrent, Estrogen Receptor Positive (ER+) Breast Cancer? Pilot Study to Compare [18F]FES-PET and [18F]FDG-PETWho this might be right forBreast Cancer Amsterdam UMC, location VUmc 40
Not applicableLooking for participantsNCT07406412What this trial is testingHormonal Regulation of Cardiometabolic Health StudyWho this might be right forMenopause Surgical University of Jyvaskyla 120
Not applicableStudy completedNCT03507088What this trial is testingStudy to Determine the Utility of FES-PET in the Prediction of Response to Fulvestrant in Women With Estrogen Positive Metastatic Breast CancerWho this might be right forMetastatic Breast Cancer Zhimin Shao 36
Large-scale testing (Phase 3)Study completedNCT03043820What this trial is testingRaloxifene Augmentation in Patients With a Schizophrenia Spectrum DisorderWho this might be right forSchizophreniaSchizoaffective DisorderSchizophreniform Disorder+1 more Iris Sommer 110
Large-scale testing (Phase 3)Active Not RecruitingNCT01674140What this trial is testingS1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast CancerWho this might be right forBreast Cancer SWOG Cancer Research Network 1,939
Early research (Phase 1)Study completedNCT01846091What this trial is testingViral Therapy In Treating Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Cancer or Metastatic Breast CancerWho this might be right forEstrogen Receptor NegativeEstrogen Receptor PositiveHead and Neck Squamous Cell Carcinoma+8 more Mayo Clinic 12
Not applicableStudy completedNCT01208779What this trial is testingEpidemiology Study in Postmenopausal Women With Estrogen Receptor Positive Breast CancerWho this might be right forHormon Receptor Positive Breast Cancer AstraZeneca 90